The more I think about it I reckon PRR shareholders are sniffing VLA.
Earlier today a long term shareholder on PRR took his profit (hot copper PRR thread). I wonder whether he then plonked a small bit of his profit in VLA.
These PRR investors are very very good and they sniff these biotechs in a large way.
The PRR story is spreading and I would not be surprised if some investors are now looking for other biotechs with FDA approval not faraway.
Very appealing SP for VLA right at the moment.
Anyway my thoughts might be off the mark but most of the time I get it right.
Cheers
Buster
DYOR
VLA Price at posting:
48.0¢ Sentiment: Buy Disclosure: Held